Letters | House Select Subcommittee on the Coronavirus Crisis (March 17, 2021–June 11, 2021)

Summary

A page of the Letters listing of the Select Subcommittee on the Coronavirus Crisis with entries dated March 17, 2021 through June 11, 2021. A May 27, 2021 entry launches an investigation into the role of the FinTech industry in PPP fraud, with letters to the chief executive officers of Kabbage, Inc. and BlueVine, Inc. Other entries include letters on a $700 Million loan to a trucking company, sent to Treasury Secretary Janet L. Yellen and Defense Secretary Lloyd J. Austin III, and a request to Administrator Isabella Guzman for disaster loan program documents. The newest entry is a response from Clyburn and Maloney to Scalise and Comer on the origins of the coronavirus.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

Letters

Clyburn and Maloney Send Response To Scalise and Comer On Requests For An Investigation Into The Origins Of The Coronavirus

June 11, 2021

Letters

Letter to the Honorable Steve Scalise, Ranking Member, Select Subcommittee on the Coronavirus Crisis and the Honorable James Comer, Ranking Member, Committee on Oversight and Reform [ PDF ]

Select Subcommittee Launches Investigation Into $700 Million Loan Issued By Trump Administration To Troubled Trucking Company

June 3, 2021

Letters

Letter to Treasury Secretary Janet L. Yellen [ PDF ]

Letter to Defense Secretary Lloyd J. Austin III [ PDF ]

Select Subcommittee Launches Investigation Into Role Of FinTech Industry In PPP Fraud

May 27, 2021

Letters

Letter to Mr. Rob Frohwin, Chief Executive Officer, Kabbage, Inc. [ PDF ]

Letter to Mr. Eyal Lifshitz, Chief Executive Officer, BlueVine, Inc. [ PDF ]

Chairs Clyburn And Velázquez Seek Key Disaster Loan Program Documents Withheld By Trump Administration

May 11, 2021

Letters

Letter to Administrator Isabella Guzman, Small Business Administration [ PDF ]

Chairs Krishnamoorthi, Maloney, Clyburn, And Lynch Request Detailed Briefing From Biden Administration On U.S. Plan To Provide Vaccines To Combat COVID Surges In India, Argentina, And Other Nations

April 30, 2021

Letters

Letter to Secretary Xavier Becerra, Department of Health and Human Services, and Secretary of State Antony Blinken, Department of State [ PDF ]

Maloney And Clyburn Launch Investigation Into Emergent BioSolutions’ Profits And Performance Under Federal Vaccine Contracts

April 19, 2021

Letters

Letter to Mr. Robert G. Kramer, President and CEO, Emergent Biosolutions, Inc., and Mr. Fuad El-Hibri, Executive Chairman, Emergent BioSolutions, Inc. [ PDF ]

Chair Clyburn Seeks Interviews With Trump Administration Advisors On Roles In Pandemic Response

April 9, 2021

Letters

Letter to Dr. Paul Alexander, former HHS Senior Advisor [ PDF ]

Letter to Dr. Scott Atlas, former Special Advisor to the President [ PDF ]

Select Subcommittee Releases New Evidence Of Trump Administration’s Failure To Address Supply Shortages

March 31, 2021

Letters

Letter to Archivist of the United States David S. Ferriero, National Archives and Records Administration [ PDF ]

Letter to Secretary Xavier Becerra, Department of Health and Human Services [ PDF ]

Clyburn Asks Biden Administration To Track Employment Disparities To Ensure An Inclusive Pandemic Recovery

March 17, 2021

Letters

Letter to Acting Director Rob Fairweather, Office of Management and Budget, and Acting Secretary Al Stewart, Department of Labor [ PDF ]

Clyburn Renews Demand For Documents On Trump Administration’s Failed Contract To Supply Masks To VA

March 17, 2021

Letters

Letter to Mr Robert L. Jenkins, Jr., Bynum & Jenkins (Counsel for Robert S. Stewart, Jr., CEO of Federal Government Experts, LLC) [ PDF ]

File and source

File

index-news-letters-3.html

Size

35,021 bytes

SHA-256

4b359f6c5b90e4fee6277674cc8bc6f86f8603c1c99cd0e65519a45aa34d1a0d

Our copy

index-news-letters-3.html

Original

No public link identified.